Stephan D Voss (Stephan Voss)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 39

Top Topics

Metastatic Renal Cell Carcinoma

Hodgkin Lymphoma

Magnetic Resonance

Top Venues

Pediatric blood & cancer

Pediatric radiology

Clinical cancer research : an official journal of the American Association for Cancer Research

JCO precision oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Kumar K Shashi, Christopher B Weldon, Stephan D Voss
Positron emission tomography in the diagnosis and management of primary pediatric lung tumors. Pediatric radiology (2024)
Emily G Greengard, Robin Williams, Branden Moriarity, Xiaowei Liu, Charles G Minard, Joel M Reid, Terrence Fisher, Elizabeth Evans, Desa Rae Pastore, Maurice Zauderer, Stephan D Voss, Elizabeth Fox, Brenda J Weigel
A phase 1/2 study of pepinemab in children, adolescents, or young adults with recurrent or refractory solid tumors: A children's oncology group consortium report (ADVL1614). Pediatric blood & cancer 71 (6) (2024)
Emily G Greengard, Robin Williams, Branden Moriarity, Xiaowei Liu, Charles G Minard, Joel M Reid, Terrence Fisher, Elizabeth Evans, Desa Rae Pastore, Maurice Zauderer, Stephan D Voss, Elizabeth Fox, Brenda J Weigel
A phase 1/2 study of pepinemab in children, adolescents, or young adults with recurrent or refractory solid tumors: A children's oncology group consortium report (ADVL1614). Pediatric blood & cancer 71 (6) (2024)
Kristy L Pilbeam, Kamnesh Pradhan, James Croop, Charles G Minard, Xiaowei Liu, Stephan D Voss, Emasenyie Isikwei, Stacey L Berg, Joel M Reid, Elizabeth Fox, Brenda J Weigel
A phase 1 trial utilizing a pharmacokinetic endpoint to determine the optimal dose of ramucirumab in children and adolescents with relapsed or refractory solid tumors, including central nervous system tumors. Pediatric blood & cancer 71 (3) (2024)
Kristy L Pilbeam, Kamnesh Pradhan, James Croop, Charles G Minard, Xiaowei Liu, Stephan D Voss, Emasenyie Isikwei, Stacey L Berg, Joel M Reid, Elizabeth Fox, Brenda J Weigel
A phase 1 trial utilizing a pharmacokinetic endpoint to determine the optimal dose of ramucirumab in children and adolescents with relapsed or refractory solid tumors, including central nervous system tumors. Pediatric blood & cancer (2024)
Emily G Greengard, Robin Williams, Branden Moriarity, Xiaowei Liu, Charles G Minard, Joel M Reid, Terrence Fisher, Elizabeth Evans, Desa Rae Pastore, Maurice Zauderer, Stephan D Voss, Elizabeth Fox, Brenda J Weigel
A phase 1/2 study of pepinemab in children, adolescents, or young adults with recurrent or refractory solid tumors: A children's oncology group consortium report (ADVL1614). Pediatric blood & cancer 71 (6) (2024)
Kristy L Pilbeam, Kamnesh Pradhan, James Croop, Charles G Minard, Xiaowei Liu, Stephan D Voss, Emasenyie Isikwei, Stacey L Berg, Joel M Reid, Elizabeth Fox, Brenda J Weigel
A phase 1 trial utilizing a pharmacokinetic endpoint to determine the optimal dose of ramucirumab in children and adolescents with relapsed or refractory solid tumors, including central nervous system tumors. Pediatric blood & cancer 71 (3) (2024)
Kristy L Pilbeam, Kamnesh Pradhan, James Croop, Charles G Minard, Xiaowei Liu, Stephan D Voss, Emasenyie Isikwei, Stacey L Berg, Joel M Reid, Elizabeth Fox, Brenda J Weigel
A phase 1 trial utilizing a pharmacokinetic endpoint to determine the optimal dose of ramucirumab in children and adolescents with relapsed or refractory solid tumors, including central nervous system tumors. Pediatric blood & cancer 71 (3) (2024)
Kristy L Pilbeam, Kamnesh Pradhan, James Croop, Charles G Minard, Xiaowei Liu, Stephan D Voss, Emasenyie Isikwei, Stacey L Berg, Joel M Reid, Elizabeth Fox, Brenda J Weigel
A phase 1 trial utilizing a pharmacokinetic endpoint to determine the optimal dose of ramucirumab in children and adolescents with relapsed or refractory solid tumors, including central nervous system tumors. Pediatric blood & cancer 71 (3) (2024)
Emily G Greengard, Robin Williams, Branden Moriarity, Xiaowei Liu, Charles G Minard, Joel M Reid, Terrence Fisher, Elizabeth Evans, Desa Rae Pastore, Maurice Zauderer, Stephan D Voss, Elizabeth Fox, Brenda J Weigel
A phase 1/2 study of pepinemab in children, adolescents, or young adults with recurrent or refractory solid tumors: A children's oncology group consortium report (ADVL1614). Pediatric blood & cancer (2024)
Kumar K Shashi, Christopher B Weldon, Stephan D Voss
Positron emission tomography in the diagnosis and management of primary pediatric lung tumors. Pediatric radiology 54 (5) (2024)
Kumar K Shashi, Christopher B Weldon, Stephan D Voss
Positron emission tomography in the diagnosis and management of primary pediatric lung tumors. Pediatric radiology (2024)
Junne Kamihara, Lisa R Diller, William D Foulkes, Orli Michaeli, Yoshiko Nakano, Kristian W Pajtler, Melissa R Perrino, Sarah R Scollon, Douglas R Stewart, Stephan D Voss, Rosanna Weksberg, Jordan R Hansford, Garrett M Brodeur
Neuroblastoma Predisposition and Surveillance-An Update from the 2023 AACR Childhood Cancer Predisposition Workshop. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Kumar K Shashi, Christopher B Weldon, Stephan D Voss
Positron emission tomography in the diagnosis and management of primary pediatric lung tumors. Pediatric radiology 54 (5) (2024)
Kumar K Shashi, Christopher B Weldon, Stephan D Voss
Positron emission tomography in the diagnosis and management of primary pediatric lung tumors. Pediatric radiology 54 (5) (2024)
Kristy L Pilbeam, Kamnesh Pradhan, James Croop, Charles G Minard, Xiaowei Liu, Stephan D Voss, Emasenyie Isikwei, Stacey L Berg, Joel M Reid, Elizabeth Fox, Brenda J Weigel
A phase 1 trial utilizing a pharmacokinetic endpoint to determine the optimal dose of ramucirumab in children and adolescents with relapsed or refractory solid tumors, including central nervous system tumors. Pediatric blood & cancer 71 (3) (2024)
Kumar K Shashi, Christopher B Weldon, Stephan D Voss
Positron emission tomography in the diagnosis and management of primary pediatric lung tumors. Pediatric radiology (2024)
Kumar K Shashi, Christopher B Weldon, Stephan D Voss
Positron emission tomography in the diagnosis and management of primary pediatric lung tumors. Pediatric radiology (2024)
Emily G Greengard, Robin Williams, Branden Moriarity, Xiaowei Liu, Charles G Minard, Joel M Reid, Terrence Fisher, Elizabeth Evans, Desa Rae Pastore, Maurice Zauderer, Stephan D Voss, Elizabeth Fox, Brenda J Weigel
A phase 1/2 study of pepinemab in children, adolescents, or young adults with recurrent or refractory solid tumors: A children's oncology group consortium report (ADVL1614). Pediatric blood & cancer 71 (6) (2024)
Emily G Greengard, Robin Williams, Branden Moriarity, Xiaowei Liu, Charles G Minard, Joel M Reid, Terrence Fisher, Elizabeth Evans, Desa Rae Pastore, Maurice Zauderer, Stephan D Voss, Elizabeth Fox, Brenda J Weigel
A phase 1/2 study of pepinemab in children, adolescents, or young adults with recurrent or refractory solid tumors: A children's oncology group consortium report (ADVL1614). Pediatric blood & cancer 71 (6) (2024)
Junne Kamihara, Lisa R Diller, William D Foulkes, Orli Michaeli, Yoshiko Nakano, Kristian W Pajtler, Melissa R Perrino, Sarah R Scollon, Douglas R Stewart, Stephan D Voss, Rosanna Weksberg, Jordan R Hansford, Garrett M Brodeur
Neuroblastoma Predisposition and Surveillance-An Update from the 2023 AACR Childhood Cancer Predisposition Workshop. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (15) (2024)
Mary-Louise C Greer, Lisa J States, David Malkin, Stephan D Voss, Andrea Schwarz Doria
Update on Whole-body MRI Surveillance for Pediatric Cancer Predisposition Syndromes. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Keri A Streby, Marguerite T Parisi, Barry L Shulkin, Brian LaBarre, Rochelle Bagatell, Lisa Diller, Stephan A Grupp, Katherine K Matthay, Stephan D Voss, Alice L Yu, Wendy B London, Julie R Park, Gregory A Yanik, Arlene Naranjo
Impact of diagnostic and end-of-induction Curie scores with tandem high-dose chemotherapy and autologous transplants for metastatic high-risk neuroblastoma: A report from the Children's Oncology Group. Pediatric blood & cancer (2023)
Eline A M Zijtregtop, Jamie Lynn Zeal, Monika L Metzger, Kara M Kelly, Christine Mauz-Koerholz, Stephan D Voss, Kathleen M McCarten, Jamie E Flerlage, Auke Beishuizen
Significance of E-lesions in Hodgkin lymphoma and the creation of a new consensus definition: A report from SEARCH. Blood advances (2023)
Aleksandra A Krokhmal, Neha Kwatra, Laura Drubach, Christopher B Weldon, Katherine A Janeway, Steven G DuBois, Junne Kamihara, Stephan D Voss
68 Ga-DOTATATE PET and functional imaging in pediatric pheochromocytoma and paraganglioma. Pediatric blood & cancer 69 (8) (2022)
Joyce C Mhlanga, Adina L Alazraki, Steve Y Cho, Hollie A Lai, Helen Ruth Nadel, Neeta Pandit-Taskar, Jing Qi, Dhanashree A Rajderkar, Stephan D Voss, Pankaj Watal, Kathleen McCarten
Imaging recommendations in pediatric lymphoma: A COG Diagnostic Imaging Committee/SPR Oncology Committee White Paper. Pediatric blood & cancer (2022)
Ellen Zhang, Amber Miller, Catherine Clinton, Kylene DeSmith, Stephan D Voss, Jon C Aster, Alanna J Church, Reza Rahbar, Nadezhda Eberhart, Katherine A Janeway, Steven G DuBois
Gamma Secretase Inhibition for a Child With Metastatic Glomus Tumor and Activated NOTCH1. JCO precision oncology 6 (2022)
Vanessa Rameh, Stephan D Voss, M Alejandra Bedoya, Danielle Beaulieu, Da Zhang, Barbara A Degar, Andy Tsai
The added value of skeletal surveys in the initial evaluation of children diagnosed with Langerhans cell histiocytosis in the era of staging 18 F-FDG PET/CT: A retrospective study. Pediatric blood & cancer 70 (1) (2022)
Kara L Davis, Elizabeth Fox, Emasenyie Isikwei, Joel M Reid, Xiaowei Liu, Charles G Minard, Stephan D Voss, Stacey L Berg, Brenda J Weigel, Crystal L Mackall
A Phase I/II Trial of Nivolumab plus Ipilimumab in Children and Young Adults with Relapsed/Refractory Solid Tumors: A Children's Oncology Group Study ADVL1412. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (23) (2022)
Sherwin S Chan, Ailish Coblentz, Aashim Bhatia, Sue C Kaste, Joyce C Mhlanga, Marguerite T Parisi, Paul G Thacker, Stephan D Voss, Elizabeth K Weidman, Marilyn J Siegel
Imaging of pediatric hematopoietic stem cell transplant recipients: A COG Diagnostic Imaging Committee/SPR Oncology Committee White Paper. Pediatric blood & cancer (2022)
Melanie M Hagleitner, Monika L Metzger, Jamie E Flerlage, Kara M Kelly, Stephan D Voss, Regine Kluge, Lars Kurch, Steve Cho, Christine Mauz-Koerholz, Auke Beishuizen
Liver involvement in pediatric Hodgkin lymphoma: A systematic review by an international collaboration on Staging Evaluation and Response Criteria Harmonization (SEARCH) for Children, Adolescent, and Young Adult Hodgkin Lymphoma (CAYAHL). Pediatric blood & cancer 67 (8) (2020)
Jennifer Seelisch, Pedro A De Alarcon, Jamie E Flerlage, Bradford S Hoppe, Sue C Kaste, Kara M Kelly, Lars Kurch, Lianna J Marks, Christine Mauz-Koerholz, Kathleen McCarten, Monika L Metzger, Dietrich Stroevesandt, Stephan D Voss, Angela Punnett
Expert consensus statements for Waldeyer's ring involvement in pediatric Hodgkin lymphoma: The staging, evaluation, and response criteria harmonization (SEARCH) for childhood, adolescent, and young adult Hodgkin lymphoma (CAYAHL) group. Pediatric blood & cancer 67 (9) (2020)
Stephan D Voss
Functional and anatomical imaging in pediatric oncology: which is best for which tumors. Pediatric radiology 49 (11) (2019)
Eric S Schafer, Rachel E Rau, Stacey L Berg, Xiaowei Liu, Charles G Minard, Alexander J R Bishop, J Carolina Romero, M John Hicks, Marvin D Nelson, Stephan D Voss, Joel M Reid, Elizabeth Fox, Brenda J Weigel, Susan M Blaney
Phase 1/2 trial of talazoparib in combination with temozolomide in children and adolescents with refractory/recurrent solid tumors including Ewing sarcoma: A Children's Oncology Group Phase 1 Consortium study (ADVL1411). Pediatric blood & cancer 67 (2) (2019)
Stephan D Voss, Mitchell S Cairo
Surveillance imaging in pediatric lymphoma. Pediatric radiology 49 (11) (2019)
Jocelyn Lewis, Kathleen McCarten, Lars Kurch, Jamie E Flerlage, Sue C Kaste, Regine Kluge, Dietrich Stoevesandt, Stephan D Voss, Kara M Kelly, Christine Mauz-Körholz, Richard A Drachtman, Monika L Metzger
Definition of cortical bone involvement in the staging of newly diagnosed pediatric Hodgkin lymphoma: A report from the International Working Group on Staging Evaluation and Response Criteria Harmonization (SEARCH). Pediatric blood & cancer 67 (4) (2019)
Meredith K Chuk, Brigitte C Widemann, Charles G Minard, Xiaowei Liu, AeRang Kim, Melanie Brooke Bernhardt, Rachel A Kudgus, Joel M Reid, Stephan D Voss, Susan Blaney, Elizabeth Fox, Brenda J Weigel
A phase 1 study of cabozantinib in children and adolescents with recurrent or refractory solid tumors, including CNS tumors: Trial ADVL1211, a report from the Children's Oncology Group. Pediatric blood & cancer 65 (8) (2018)
Jean-Marc Gauguet, Tamara Pace-Emerson, Frederick D Grant, Suzanne Shusterman, Steven G DuBois, A Lindsay Frazier, Stephan D Voss
Evaluation of the utility of 99m Tc-MDP bone scintigraphy versus MIBG scintigraphy and cross-sectional imaging for staging patients with neuroblastoma. Pediatric blood & cancer 64 (11) (2017)
Allison F O'Neill, Stephan D Voss, Jyothi P Jagannathan, Junne Kamihara, Callie Nibecker, Elena Itriago-Araujo, Serena Masciari, Erin Parker, Mauricio Barreto, Wendy B London, Judy E Garber, Lisa Diller
Screening with whole-body magnetic resonance imaging in pediatric subjects with Li-Fraumeni syndrome: A single institution pilot study. Pediatric blood & cancer 65 (2) (2017)